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Summary: Glimm et al. (2010) and Tamhane et al. (2010) studied the problem of testing a primary and a secondary
endpoint, subject to a gatekeeping constraint, using a group sequential design (GSD) with K = 2 looks. In this paper we
greatly extend the previous results to multiple (K > 2) looks. If the familywise error rate (FWER) is to be controlled at
a preassigned α level then it is clear that the primary boundary must be of level α. We show under what conditions one
α-level primary boundary is uniformly more powerful than another. Based on this result we recommend the choice of the
O’Brien and Fleming (1979) boundary over the Pocock (1977) boundary for the primary endpoint. For the secondary
endpoint the choice of the boundary is more complicated since under certain conditions the secondary boundary can be
refined to have a nominal level α′ > α, while still controlling the FWER at level α, thus boosting the secondary power.
We carry out secondary power comparisons via simulation between different choices of primary-secondary boundary
combinations. The methodology is applied to the data from the RALES study (Pitt et al., 1999; Wittes et al., 2001).
Key words: Familywise error rate; Gatekeeping; Lan-DeMets error spending function approach; Multiple compar-
isons; Multiple endpoints; O’Brien-Fleming boundary; Pocock boundary; Primary power; Secondary power.
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1. Introduction
Gatekeeping procedures for testing multiple hierarchical objectives such as tests on multiple
endpoints have been been studied by many authors in the last 15 years, see, e.g., Dmitrienko
and Tamhane (2007, 2009). For the most part, these studies are restricted to fixed sample
designs. However, group sequential designs (GSDs) have become increasingly more common
in clinical trials since the early works of Pocock (1977) and O’Brien and Fleming (1979);
Jennison and Turnbull (2000) have given a thorough overview of the subject. Tang and Geller
(1999), Jennison and Turnbull (1993) and Maurer and Bretz (2013) have addressed certain
aspects of multiple testing in GSDs. Still, there is a pressing need to develop procedures at
the interface of gatekeeping and group sequential designs. This paper addresses a practically
important problem at this interface.
Hung et al. (2007) were the first to study a gatekeeping test on a primary and a secondary
endpoint using a GSD with two looks (or stages). They showed that the fixed-sequence testing
strategy of propagating α from a rejected hypothesis to an unrejected one, used effectively
in gatekeeping and graphical procedures (Bretz et al. (2009)), inflates the type I error rate
when used in a GSD. Glimm et al. (2010) and Tamhane et al. (2010) studied this problem
analytically and showed how to determine the critical boundaries for the two endpoints to
control the familywise type I error rate (FWER). Both these papers focused on the two-look
(K = 2) case. In this paper we study this problem in much greater depth and extend the
previous results to multiple looks (K > 2).
The outline of the paper is as follows. Section 2 sets up the notation and gives the statement
of the problem. Section 3 discusses the choice of the primary boundary. Section 4 discusses
the choice of the secondary boundary. This section is divided into three subsections. The first
subsection reviews the previous results forK = 2, while the second subsection gives new results
for K > 2. Both these subsections consider the least favorable case (in terms of maximizing the
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FWER) of the correlation ρ between the primary and the secondary endpoints equal to 1. The
third subsection gives the secondary boundaries for the known ρ case to illustrate how much
the secondary boundary can be relaxed if ρ < 1. Section 5 gives simulated power comparisons
between different choices of primary and secondary boundaries. Section 6 gives a clinical trial
example to illustrate the methodology presented in the paper. Section 7 gives an extension of
the procedure studied in the paper. Section 8 gives concluding remarks. To keep the length
of the paper within limits only a simpler and shorter proof of a special case of Theorem 1 is
included in the Appendix; a longer and a more technical proof of that theorem is included
in a Web Appendix, which also includes proofs of Theorems 4 and 5, and the R program to
compute the various boundaries necessary to implement the proposed methodology.
2. Problem Formulation and Notation
We will assume the following normal theory set up, which applies asymptotically to broad
types of data including survival and binary data. Consider a parallel arm trial to compare
a treatment with a control or placebo on a primary and a secondary endpoint, which are to
be tested hierarchically with the primary endpoint acting as a gatekeeper for the secondary
endpoint. For each patient we observe a bivariate normal response on the primary and the
secondary endpoints with means (µt1, µt2) for the treatment group and (µc1, µc2) for the control
group; the variances (σ21, σ
2
2) and the correlation coefficient ρ are assumed to be common for
the two groups. Let δ1 = µt1 − µc1 and δ2 = µt2 − µc2 denote the primary and secondary
treatment effects, respectively. We want to test two hypotheses, H1 : δ1 = 0 and H2 : δ2 = 0
against upper one-sided alternatives where H2 is tested only if H1 is rejected.
We use a GSD with K > 2 stages. In the ith stage of the trial we have ni patients on each
arm. Denote the cumulative sample sizes on each arm by Ni = n1+. . .+ni and the information
times by ti = Ni/NK (1 6 i 6 K). We assume that the information times are the same for
A Gatekeeping Test in a Group Sequential Design 3
the primary and secondary endpoints. All except one example (the RALES data example in
Section 6) given in this paper assume equal group sizes and so ti = i/K (1 6 i 6 K);
however. theoretical results apply more generally. This assumption will not be repeated in
those examples.
Denote the critical boundary for the primary endpoint by (c1, . . . , cK) and that for the
secondary endpoint by (d1, . . . , dK). We want to determine these decision boundaries so as to
strongly control the FWER for any specified α (Hochberg and Tamhane, 1987):
FWER = P{Reject at least one true Hi (i = 1, 2)} 6 α (1)
regardless of whether H1 or H2 is true or both are true.
The Lan and Demets (1983) flexible error spending function approach used in the example
in Section 6 does not require prespecification of the number or the timings of the looks. In
that example we will adapt the fixed GSD boundaries to the flexible error spending function
boundaries.
At the ith look, let (Xi, Yi) denote the standardized sample mean test statistics for the two
endpoints, which are assumed to be bivariate normal with mean vector (∆1i,∆2i) where
∆1i =
δ1
σ1
√
Ni
2
and ∆2i =
δ2
σ2
√
Ni
2
(1 6 i 6 K)
and correlation coefficient ρ. Define the standardized treatment effects at Stage K for the two
endpoints by
∆1 = ∆1K =
δ1
σ1
√
NK
2
and ∆2 = ∆2K =
δ2
σ2
√
NK
2
.
Then ∆1i = γi∆1 and ∆2i = γi∆2 where γi =
√
ti (1 6 i 6 K). (We note that in Tamhane
et al. (2010), ∆1 and ∆2 were defined as δ1
√
n1 and δ2
√
n1, respectively; also a single-sample
study was assumed in contrast to the two-sample study assumed in the present paper.)
The correlation structure of (X1, . . . , XK) and (Y1, . . . , YK) can be readily shown to be as
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follows.
corr(Xi, Xj) = corr(Yi, Yj) = γij =
γi
γj
(1 6 i < j 6 K)
corr(Xi, Yi) = ρ (1 6 i 6 K)
corr(Xi, Yj) = corr(Xj, Yi) = ργij (1 6 i < j 6 K).
We will restrict attention to what Glimm et al. (2010) called the stagewise hierarchical rule
in which H1 is tested using the primary decision boundary until either it is rejected, i.e.,
Xi > ci for some i 6 K and then H2 is tested or the trial terminates without rejecting H1
and hence also H2. If H1 is rejected at the ith look then H2 is rejected if Yi > di; otherwise
H2 is retained and the trial terminates. We will denote this procedure by Pa. See, however,
see Section 7, which studies a more general procedure Pb that conducts sequential tests on
H2 until it is rejected or the trial stops.
3. Choice of the Primary Boundary
It is clear that since H1 is a gatekeeper for H2, the primary boundary must control the type
I error under H1 at level α. Any such α-level boundary can be chosen for this purpose. The
following theorem tells how to choose a more powerful α-level boundary.
Theorem 1: Suppose (X1, . . . , XK) has a multivariate normal distribution as defined
above. Consider two different α-level tests: Test A with group sequential boundary (a1, . . . , aK)
and Test B with group sequential boundary (b1, . . . , bK) for testing H1: δ1 = 0 vs δ1 > 0. If for
some k∗ ∈ {1, . . . , K − 1}, ai > bi for i = 1, . . . , k∗ and ai < bi for i = k∗ + 1, . . . , K, and
if the total sample size is the same for both the tests then Test A is uniformly more powerful
than Test B for all δ1 > 0.
An intuitive explanation for this result is that if test A tends to stop later than test B,
then test A always makes a final decision based on more data than test B and so hs more
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power. An extreme case for k∗ = K − 1 is when a1 = . . . = aK−1 = ∞ and so test A always
takes the maximum possible sample size, while test B tends to take fewer observations. Then
application of the Neymann-Pearson lemma implies that test A has a higher power. In the
Appendix, we use a likelihood ratio argument to prove Theorem 1 for cases where k∗ = K− 1
and test A never stops earlier than test B. However, this method does not generalize to cases
where k∗K − 2 and it is possible for test A to stop before test B. Our proof for such cases is
longer and more technical and is given in the Web Appendix.
Consider a corollary to this theorem for two classical group sequential boundaries: the
O’Brien-Fleming (OBF) boundary and the Pocock (POC) boundary. It is clear that the OBF
boundary corresponds to Test A and the POC boundary corresponds to Test B. So the OBF
boundary is uniformly more powerful than the POC boundary. Thus given a choice between
these two boundaries we choose the OBF boundary for the primary endpoint.
4. Choice of the Secondary Boundary
Now consider the choice of the secondary boundary to control the FWER under H2 : δ2 = 0
when H1 is false. This FWER (which we will also refer to as the secondary type I error
probability) is a function of the joint distribution of the Xi’s and the Yi’s, and so of the
unknown parameters ∆1 and ρ (as well as of the known information fractions). We denote it
by α2(∆1, ρ), where
α2(∆1, ρ) =
K∑
i=1
PH2 {X1 6 c1, . . . , Xi−1 6 ci−1, Xi > ci;Yi > di} . (2)
Let α2 = max∆1,ρ α2(∆1, ρ). Then we need to determine (d1, . . . , dK) such that α2 6 α.
4.1 Summary of Results for K = 2
We summarize the main results from Tamhane et al. (2010).
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Theorem 2: If c1 > d1 then α2 = max∆1,ρ α2(∆1, ρ) is achieved at ∆1 = ∆
0
11 = (c1 −
d1)/γ1 and ρ = 1 and
α2 = 1− PH2(Y1 6 d1, Y2 6 d2) = 1− Φ2(d1, d2|γ1), (3)
where Φ2(·, ·|γ) denotes the standard bivariate normal c.d.f. with correlation coefficient γ.
Thus in order to control α2 6 α, (d1, d2) must be an α-level boundary, i.e., PH2(Y1 6 d1, Y2 6
d2) = Φ2(d1, d2|γ1) = 1− α.
This theorem shows that Hung et al.’s (2007) Strategy 1 will be liberal since it uses d1 =
d2 = zα, the upper α critical point of the standard normal distribution. If α = 0.05 then
z.05 = 1.645 and α2 = 1− Φ2(1.645, 1.645|
√
1/2) = 0.08 > 0.05.
Note that max∆1,ρ α2(∆1, ρ) is independent of (c1, c2) although where this maximum occurs
w.r.t. ∆1 depends on (c1, d1). Any α-level boundary can be chosen for (d1, d2) as long as c1 > d1.
For example, (c1, c2) can be the OBF boundary and (d1, d2) can be the POC boundary. The
0.05-level boundaries are (c1, c2) = (1.678
√
2, 1.678) and (d1, d2) = (1.876, 1.876). In this case
max∆1,ρ α2(∆1, ρ) is equal to 0.05 and is attained at ∆1 = ∆
0
11 = (1.678
√
2− 1.876)/√0.5 =
0.703 as shown in Figure 3 of Tamhane et al. (2010).
Next we consider the case c1 < d1 and c2 > d2. For example, (c1, c2) is the POC boundary
and (d1, d2) is the OBF boundary.
Theorem 3: If (c1, c2) and (d1, d2) are α-level boundaries with c1 < d1 and c2 > d2 then
α2 = max∆1,ρ α2(∆1, ρ) is achieved at ∆1 = ∆
0
12 = (c2 − d2)/γ2 = c2 − d2 and the associated
α2 < α. So the secondary boundary can be refined to be more liberal with some nominal level
α′ > α to make the associated α2 = α, thus boosting the secondary power.
To obtain the refined boundary (d1, d2), note that under the least favorable configuration
ρ = 1, using E(Xi) = γi∆1, we have Yi = Xi − γi∆1 (i = 1, 2). So we can write
α2 = P{Y1 > max(c1 − γ1∆1, d1)}+ P{Y1 6 c1 − γ1∆1, Y2 > max(c2 − γ2∆1, d2)}. (4)
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We can parameterize (d1, d2) by a single unknown d and solve the equation α2 = α for d. As an
illustration, suppose for α = 0.05, the primary boundary is POC with c1 = c2 = 1.876 and the
secondary boundary is OBF with d1 = d
√
2, d2 = d with d = 1.678. For this boundary it turns
out that α2 = 0.039 using (4). We can find a refined OBF boundary (d1, d2) by setting (4) equal
to α = 0.05 and solving for d. The solution is d = 1.570. Thus the refined secondary boundary
is (1.570
√
2, 1.570). The nominal α level of this refined boundary is α′ = 0.063 > 0.05. These
calculations are shown in the top panel of Table 1.
From these theorems we conclude that ρ = 1 is the least favorable configuration in that
it maximizes α2(∆1, ρ). In practice, of course, ρ is always less than 1 (an exception being
noninferiority-superiority testing, where the same statistic is used for both tests). So it is of
interest to know how α2(∆1, ρ) behaves as a function of ρ. Figure 3 in Tamhane et al. (2010)
indicates that max∆1 α2(∆1, ρ) < α if ρ < 1, so a more liberal and more powerful secondary
boundary can be used if ρ is known. We will extend these results to K > 2 in Section 4.3.
If ρ is estimated from the first stage data then Tamhane et al. (2012) showed how an upper
confidence limit on ρ can be used instead.
If c1 > d1 and c2 < d2 then it follows that ∆
0
11 > 0 > ∆
0
12. For example, for the OBF-POC
boundary combination and α = 0.05, we have ∆011 = (1.678
√
2 − 1.876)/√0.5 = 0.703 and
∆012 = 1.678 − 1.876 = −0.198. Thus, as ∆1 is increased from −∞, it crosses ∆012 first when
max(c2−γ2∆1, d2) changes from c2−γ2∆1 to d2, then it crosses ∆011 when max(c1−γ1∆1, d1)
changes from c1 − γ1∆1 to d1. This gives us the following expressions for the two peak values
of α2(∆1, ρ = 1):
α2(∆1, ρ = 1) =
 P (Y1 > c1 − γ1∆012) + P (Y1 6 c1 − γ1∆012, Y2 > d2) (∆1 = ∆012)P (Y1 > d1) + P (Y1 6 d1, Y2 > d2) (∆1 = ∆011).
The overall maximum clearly occurs at ∆1 = ∆
0
11 and equals α since (d1, d2) is an α-level
boundary.
8 Biometrics, December 201x
4.2 New Results for K > 2
We first derive a necessary and sufficient condition for the secondary boundary {d1, . . . , dK}
to be an α-level boundary, i.e., PH2{Y1 6 d1, . . . , YK 6 dK} = 1− α.
Theorem 4: The secondary type I error α2(∆1, ρ) is bounded above by
1− PH2{Y1 6 d1, . . . , YK 6 dK},
and this bound is achieved if and only if
∆011 = · · · = ∆01,K−1 > ∆01K and ρ = 1. (5)
In all other cases, α2 = max∆1,ρ α2(∆1, ρ) < α. So the secondary boundary can be refined to
be more liberal with nominal level α′ > α to make the associated α2 = α, thus boosting the
secondary power.
Theorem 2 is a special case for K = 2 of the above theorem. In this case if (c1, c2) and (d1, d2)
are both α-level boundaries and c1 > d1 then c2 6 d2, and hence ∆011 > 0 and ∆012 6 0. So
condition (5) is obviously satisfied. In most practical situations, condition (5) will not be
satisfied for K > 2 unless the primary and secondary boundaries are the same. Hence α2 will
be less than α. Analogous to the K = 2 case, we can refine the secondary boundary to increase
α2 to α as follows.
Generalizing the formula (4) we can write
α2 =
K∑
i=1
P{Y1 6 c1 − γ1∆1, . . . , Yi−1 6 ci−1 − γi−1∆1, Yi > max(ci − γi∆1, di)}. (6)
As before, given any α-level primary boundary (c1, . . . , cK), we can find a refined secondary
boundary parameterized by a single unknown constant d by solving the equation α2 = α
for d. For example, if we choose the secondary boundary to be the OBF boundary then
di = d/γi (1 6 i 6 K). We illustrate this calculation for K = 3 and K = 4 below.
Consider two boundary combinations: OBF for primary and POC for secondary (denoted
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as OBF-POC) and POC for primary and OBF for secondary (denoted as POC-OBF). In both
cases, the condition (5) is not satisfied and hence α2 < α. The middle panel of Table 1 gives
the original boundaries with α2 < α associated with them for K = 3. It also gives the refined
secondary boundary with α2 = α and nominal level α
′ > α. The refined secondary boundary
has the same form as the original secondary boundary (i.e., OBF or POC) but has α2 = α.
The bottom panel of Table 1 gives analogous results for K = 4.
[Table 1 about here.]
Generalizing the results for K = 2, the sharp peaks (where the derivative does not exist) in
FWER plots for ρ = 1 occur at ∆1 = ∆
0
1i = (ci − di)/γi (1 6 i 6 K). Thus there are exactly
K such peaks and so the continuous problem of finding max∆1 α2(∆1, ρ = 1) reduces to the
discrete problem of searching for the maximum of K values of α2(∆
0
1i, ρ = 1) for i = 1, . . . , K.
Figure 1 illustrates this phenomenon for K = 3 with the OBF primary boundary and the
refined POC secondary boundary with three sharp peaks. As shown in Figure 1, these peaks
occur at ∆1 = ∆
0
1i (i = 1, 2, 3), which are listed in Table 2 for the OBF-POC boundary
combination under Refined Boundaries.
[Figure 1 about here.]
[Table 2 about here.]
In general, the ordering of the ∆01i values depends on the choice of the primary and secondary
boundaries as well as the information times of the looks. For the OBF-POC boundary combi-
nation with equispaced information times of the looks, it is easy to show that ∆011 > · · · > ∆01K ,
as seen in Table 2.
For K > 2, we can write the following expression for ∆1 = ∆
0
1i:
α2(∆
0
1i, ρ = 1) =
i−1∑
j=1
P{Yk 6 ck − γk∆01i (1 6 k 6 j − 1), Yj > cj − γj∆01i}
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+
K∑
j=i
P{Yk 6 ck − γk∆01i (1 6 k 6 j − 1), Yj > dj}.
At ∆1 = ∆
0
11, this expression equals
P (Y1 > d1) + P (Y1 6 d1, Y2 > d2) + P (Y1 6 d1, Y2 6 c2 − γ2∆011, Y3 > d3) + · · ·
+P (Y1 6 d1, Y2 6 c2 − γ2∆011, . . . , YK−1 6 cK−1 − γK−1∆011, YK > dK),
which is < α since ci − γi∆011 < di for i = 1, . . . , K − 1 unless ∆011 = · · · = ∆01,K−1 according
to Theorem 4.
4.3 Secondary Boundary Calculation for Known ρ
The secondary boundary calculations given in the previous section have assumed the least
favorable value of ρ = 1. As noted before, in practice ρ is generally less than 1. So it is of
interest to determine how much the secondary boundary can be refined if ρ < 1 is assumed
to be known. Analogous to Table 1 in Tamhane et al. (2010), we calculated the secondary
boundary for selected values of ρ for α = 0.05 in the top and the bottom panels of Table 3
for K = 3 and K = 4, respectively. This calculation involves simultaneous maximization with
respect to ∆1 and root finding with respect to d; the algorithm iterates between these two
steps. The expression for α2(∆1, ρ) used in these calculations and its derivation are given in
the Web Appendix.
[Table 3 about here.]
It is clear that the secondary boundary becomes more liberal as the assumed ρ gets smaller.
However, if the true ρ is larger than the assumed ρ then the FWER under H2 will not be
controlled at level α. Therefore direct power comparisons between the secondary boundaries
for different ρ are not possible. For example, if we compare the powers for the boundary
combination OBF-POC for ρ = 0.4 and ρ = 0.6. Then clearly, the boundary combination for
ρ = 0.4 will give a higher power than that for ρ = 0.6. However, if the true ρ = 0.5 then the
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former will not control the FWER while the latter would. Thus the gain in power is obtained
at the expense of excess secondary type I error.
5. Power Simulations
For studying secondary powers we will restrict attention to combinations of the OBF and POC
boundaries. Since the OBF boundary is uniformly more powerful than the POC boundary for
the primary endpoint, we will only consider OBF-POC and OBF-OBF combinations. If we
choose the OBF-POC combination then since condition (5) in Theorem 4 is not satisfied,
the POC boundary can be refined to level α′ > α. If we use the OBF-OBF combination then
condition (5) is satisfied; so the secondary OBF boundary cannot be refined. Thus we compare
the powers of two primary-secondary boundary combinations: (1) α-level OBF boundary for
the primary endpoint and α′-level POC boundary for the secondary endpoint, and (2) α-level
OBF boundary for both the primary and secondary endpoints. Figure 2 gives the secondary
power plots for these two combinations as functions of ∆2 for α = 0.05, ρ = 0.5,∆1 = 1.0, 3.0
and K = 3. We see that for ∆1 = 1.0, the differences in the powers between the two boundary
combinations are very small, but the boundary combination (1) is slightly more powerful. For
∆1 = 3.0, the boundary combination (1) is uniformly and substantially more powerful.
[Figure 2 about here.]
6. Example
To illustrate the methodology presented in this paper we use the data from the Randomized
Aldactone Evaluation Study (RALES) (Pitt et al., 1999; Wittes et al., 2001). The goal of the
study was to evaluate the efficacy of spironolactone for patients who had severe heart failure.
The study used a multicenter double-blind randomized trial with 822 patients assigned to
the treatment (25 mg of spironolactone daily) and 841 patients assigned to placebo. The
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primary endpoint was death from all causes. The actual numbers of patients enrolled in the
two arms were less than these numbers and are given in Table 4. There were a number of
secondary endpoints, but none was evaluated formally. For illustration purposes we will use
sudden cardiovascular (CV) deaths as the secondary endpoint.
The trial employed a group sequential design with Lan and Demets (1983) stopping bound-
ary using the OBF error spending function: α(t) = 2[1−Φ(zα/2/
√
t)]. The trial was monitored
semi-annually by the Data Safety Monitoring Board (DSMB) and it was stopped early at the
5th look when the log-rank statistic for comparing the treatment and placebo group exceeded
the critical threshold. The trial was planned assuming a total of 1080 all-cause deaths by the
end of the trial. The looks occurred approximately at equal information times spaced 0.125
units (or 135 all-cause deaths) apart, which corresponds to K = 8 looks in a fixed GSD trial.
The one-sided 0.025-level critical values for the primary endpoint using the OBF error
spending function are given in Table 4 along with the log-rank statistics for the observed
number of deaths and the information fractions until the 5th look. We see that, in fact, the
log-rank statistic crossed the boundary at the 4th look. In the actual trial this happened at
the 5th look because the data on the number of deaths was not fully reported and thus was
not up-to-date when the DSMB meetings took place.
Next we test the secondary endpoint at the 4th look. The data for the secondary endpoint
is given in Table 5, where the information fractions are taken from Table 4, which are based
on all-cause deaths. Since the expected total number of sudden CV deaths at the end of
the trial was not specified, the information fractions based on sudden CV deaths cannot be
computed. However, the total number of all-cause deaths and sudden CV deaths at each look
are almost perfectly correlated with a correlation coefficient of 0.999. Therefore the correlations
between the Yi’s needed to compute the secondary boundary, which are equal to the ratios of
the total numbers of sudden CV deaths at different looks, are unaffected if we use all-cause
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deaths instead. Another important point to note is that the alpha-spending for the secondary
boundary is based on the information fractions for the primary boundary. But this change of
time scale can be justified by the theory in Lan and Demets (1983) and also Proschan et al.
(2006), pp. 87-89, and almost perfect correlation between the two sets of information fractions.
The log-rank statistic at the 4th look equals only 1.268 and fails to cross the Pocock boundary
value of 2.505 calculated from the error spending function: α(t) = α ln[1+(e−1)t]. At the 5th
look, when the actual trial terminated, the log-rank statistic is 2.224, which still fails to exceed
the Pocock critical value of 2.532. We could use the refined Pocock boundary by applying the
method developed in Section 4.2 to the above error spending function. For this calculation we
assumed that the number of looks is 8 and the timings of the future looks are equispaced at
(1 − 0.61)/3 = 0.13 units apart, i.e., at t6 = 0.74, t7 = 0.8, t8 = 1. The nominal significance
level of the refined Pocock boundary turns out to be α′ = 0.0473. The corresponding critical
value at the 5th look is 2.259, which is still not crossed by the secondary log-rank statistic.
Thus we fail to declare statistical significance for the sudden CV death secondary endpoint.
In the above, we have assumed that the future looks are equispaced. For sensitivity analysis
purposes, we considered two other sequences of future information times in which t6−t5, t7−t6
and t8−t7 are in 2:1:1 and 1:1:2 ratios. The corresponding information times are t6 = 0.81, t7 =
0.90, t8 = 1. and t6 = 0.71, t7 = 0.81, t8 = 1. The α
′-levels of the refined Pocock boundaries
for these two sequences are 0.0480 and 0.0459, respectively, which don’t differ very much from
α′ = 0.0473 for the equispaced information fractions refined Pocock boundary. In making a
positive claim for a secondary endpoint based on a refined test of the secondary endpoint, it
could be advisable for investigators to report a similar sensitivity analysis.
[Table 4 about here.]
[Table 5 about here.]
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7. Extensions
The procedure Pa tests H2 only once and if it is not rejected then the trial stops. In practice,
the DMC may choose not to stop the trial at the interim look when H1 is rejected but H2 is
not rejected if the overall benefit/risk is not fully convincing. In that case a DMC may want
to continue the trial and sequentially test H2 until it is rejected or the trial stops. We denote
this procedure by Pb. Glimm et al. (2010) referred to this procedure as the overall hierarchical
rule. They gave an expression for its secondary type I error for K = 2. Its straightforward
generalization and an upper bound on it are given in the following theorem.
Theorem 5: Denote the secondary type I errors of procedures Pa and Pb by αa2(∆1, ρ)
and αb2(∆1, ρ), respectively, where α
a
2(∆1, ρ) is the same as α2(∆1, ρ) given by (2). Then we
have
αb2(∆1, ρ) = α
a
2(∆1, ρ)
+
K−1∑
i=1
K∑
j=i+1
P (X1 6 c1, · · · , Xi−1 6 ci−1, Xi > ci, Yi 6 di, · · · , Yj−1 6 dj−1, Yj > dj)
6 1− PH2{Y1 6 d1, . . . , YK 6 dK}. (7)
This upper bound is achieved if and only if ρ = 1 and ∆1 > max16i6K(∆01i).
The proof of the theorem is given in the Web Appendix. Note that this upper bound is
equal to α if and only if {d1, . . . , dK} is an α-level boundary. Thus under the least favorable
configuration of ρ = 1 and ∆1 > max16i6K(∆01i), the procedure Pb must use the regular
α-level boundary for the secondary endpoint; any refinement is not possible.
Some other useful extensions that could be followed up include multiple primary and
secondary endpoints, either unordered or hierarchically ordered.
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8. Concluding Remarks
Some limitations of the proposed methodology stemming from the underlying assumptions
should be noted here. One assumption is that ρ and ∆1 are assumed to remain fixed throughout
the trial. In practice, they might vary if the patient population changes over time. If the trial
is designed under the least favorable configuration of ρ = 1 and ∆1 = argmax{α2(∆1, ρ = 1)}
then the procedure will control the FWER for all ρ and ∆1 and so will be robust to changes
in these parameters.
Although the theory developed is for the case of a fixed GSD with a prespecified number and
timings of the looks, we have shown through an example, how this theory can be applied to
the flexible GSD using the error spending function approach of Lan and Demets (1983). Our
general recommendation is to use this latter approach with a O’Brien-Fleming type boundary
for the primary endpoint and a refined Pocock type boundary for the secondary endpoint.
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Appendix
Proof of a Special Case of Theorem 1. We consider the special case k∗ = K−1, i.e., ai > bi
for 1 6 i 6 K − 1 and aK > bK . However, we assume that the distribution of (X1, . . . , XK)
has monotone likelihood ratio (MLR) thus relaxing the assumption of multivariate normality.
Denote by A the group sequential test defined by the boundary (a1, . . . , aK) and by B the
group sequential test defined by the boundary (b1, . . . , bK), where ai > bi (1 6 i 6 K − 1)
and aK < bK . Both A and B are α-level tests. Denote by fδ(x1, . . . , xK) the joint probability
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density function (p.d.f.) of (X1, . . . , XK) under δ. When δ = 0 this is the joint null p.d.f. under
H1 : δ1 = 0.
First consider the K = 2 case, where a1 > b1, a2 < b2. Equality of type I errors of A and B
yields the equation∫ b1
−∞
∫ b2
−∞
f0(x1, x2)dx1dx2 =
∫ a1
−∞
∫ a2
−∞
f0(x1, x2)dx1dx2.
Write the LHS of the above equation as∫ b1
−∞
∫ a2
−∞
f0(x1, x2)dx1dx2 +
∫ b1
−∞
∫ b2
a2
f0(x1, x2)dx1dx2
and the RHS as ∫ b1
−∞
∫ a2
−∞
f0(x1, x2)dx1dx2 +
∫ a1
b1
∫ a2
−∞
f0(x1, x2)dx1dx2.
Canceling the common term from both sides of the equation we get∫ b1
−∞
∫ b2
a2
f0(x1, x2)dx1dx2 =
∫ a1
b1
∫ a2
−∞
f0(x1, x2)dx1dx2. (A.1)
The LHS of the above equation is the probability under H1 that A rejects H1 but B does not
and the RHS is the probability under H1 that B rejects H1 but A does not.
To show that A is uniformly more powerful than B under δ > 0 we need to show that∫ b1
−∞
∫ b2
a2
fδ(x1, x2)dx1dx2 >
∫ a1
b1
∫ a2
−∞
fδ(x1, x2)dx1dx2.
Let
rδ(x1, x2) =
fδ(x1, x2)
f0(x1, x2)
denote the likelihood ratio (LR) of the joint p.d.f.’s under δ > 0 and under δ = 0. Then since
x2 is a sufficient statistic for δ, rδ(x1, x2) is a function only of x2, so we can denote it simply
by rδ(x2). Then by the monotone likelihood ratio (MLR) property, it follows that rδ(x2) is
an increasing function of x2. Therefore we can write∫ b1
−∞
∫ b2
a2
fδ(x1, x2)dx1dx2 =
∫ b1
−∞
∫ b2
a2
f0(x1, x2)rδ(x2)dx1dx2
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> rδ(a2)
∫ b1
−∞
∫ b2
a2
f0(x1, x2)dx1dx2
= rδ(a2)
∫ a1
b1
∫ a2
−∞
f0(x1, x2)dx1dx2 (from (A.1))
>
∫ a1
b1
∫ a2
−∞
f0(x1, x2)rδ(x2)dx1dx2
=
∫ a1
b1
∫ a2
−∞
fδ(x1, x2)dx1dx2,
which was to be shown.
This result can be generalized to the K > 2 case by defining two sets of sample paths:
A = {(x1, . . . , xK−1) : Neither A nor B rejects in stages 1, . . . , K − 1}
and
B = {(x1, . . . , xK−1) : B rejects but A does not reject in stages 1, . . . , K − 1}.
In A we have xi 6 bi < ai and in B we have bi < xi 6 ai for i = 1, . . . , K − 1. For K = 2,
A = [−∞, b1] and B = [b1, a1]. If (x1, . . . , xK−1) ∈ A and xK ∈ [aK , bK ] then A rejects H1 but
B does not. On the other hand, if (x1, . . . , xK−1) ∈ B and xK < aK then B rejects H1 but A
does not. The proof then essentially proceeds as in the K = 2 case with obvious extensions
(e.g., xK replacing x2). 
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Figure 1. FWER Plot for OBF primary and Refined POC secondary boundary for K = 3
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Figure 2. Secondary power as a function of ∆2, ρ = 0.5. K = 2, ∆1 = 1 (top left panel)
and ∆1 = 3 (top right panel), K = 3, ∆1 = 1 (bottom left panel) and ∆1 = 3 (bottom right
panel)
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Table 1
Original and refined boundaries1,2,3 (α = 0.05)
K = 2 Original Boundaries Refined Secondary Boundary
Primary Secondary α2 Secondary α
′
OBF: c = 1.678 POC: d = 1.876 0.050 Secondary boundary not refined
POC: c = 1.876 OBF: d = 1.678 0.039 OBF: d = 1.570 0.063
K = 3 Original Boundaries Refined Secondary Boundary
Primary Secondary α2 Secondary α
′
OBF: c = 1.710 POC: d = 1.992 0.039 POC: d = 1.881 0.063
POC: c = 1.992 OBF: d = 1.710 0.033 OBF: d = 1.535 0.073
K = 4 Original Boundaries Refined Secondary Boundary
Primary Secondary α2 Secondary α
′
OBF: c = 1.733 POC: d = 2.067 0.033 POC: d = 1.877 0.075
POC: c = 2.067 OBF: d = 1.733 0.028 OBF: d = 1.513 0.080
1 OBF primary boundary: (c
√
2, c), OBF secondary boundary: (d
√
2, d).
2 POC primary boundary: (c, c), POC secondary boundary: (d, d).
3 For the refined secondary boundary α2 = α = 0.05 and α
′ > α is its nominal α-level.
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Table 2
∆01i Values for original and refined boundaries (K = 3, α = 0.05)
Boundary Combination Original Boundaries Refined Boundaries
∆011 ∆
0
12 ∆
0
13 ∆
0
11 ∆
0
12 ∆
0
13
OBF-POC 1.678 0.124 −0.283 1.871 0.261 −0.171
POC-OBF −1.678 −0.124 0.283 −1.153 0.138 0.458
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Table 3
Secondary boundary critical constants d for different combinations of the OBF and POC boundaries for K = 3 (top
panel), K = 4 (bottom panel), α = 0.05 and equispaced information times
K = 3 Primary Secondary ρ
Boundary Boundary 0.0 0.2 0.4 0.6 0.8 1.0
OBF OBF 1.356 1.378 1.408 1.451 1.519 1.710
(2.945) (2.481) (2.062) (1.524) (1.002) (0)
OBF POC 1.645 1.670 1.698 1.729 1.767 1.881
(∞) (4.376) (3.561) (2.940) (2.596) (1.871)
POC OBF 1.185 1.211 1.245 1.291 1.359 1.534
(3.001) (2.587) (2.143) (1.667) (1.128) (0.458)
POC POC 1.645 1.666 1.695 1.736 1.798 1.992
(∞) (3.807) (2.987) (2.148) (1.319) (0)
The OBF secondary boundary is di = d
√
3/i, the POC secondary boundary is di = d.
K = 4 Primary Secondary ρ
Boundary Boundary 0.0 0.2 0.4 0.6 0.8 1.0
OBF OBF 1.321 1.345 1.378 1.425 1.500 1.733
(2.884) (2.461) (2.043) (1.472) (0.956) (0)
OBF POC 1.645 1.669 1.695 1.726 1.767 1.877
(∞) (5.752) (3.507) (2.445) (1.547) (0.812)
POC OBF 1.140 1.166 1.201 1.249 1.323 1.513
(3.011) (2.597) (2.160) (1.655) (1.145) (0.554)
POC POC 1.645 1.674 1.712 1.761 1.835 2.067
(∞) (3.883) (3.014) (2.200) (1.314) (0)
The OBF secondary boundary is di = d
√
4/i, the POC secondary boundary is di = d.
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Table 4
One-Sided 0.025-Level Lan-DeMets Boundary Using the O’Brien-Fleming Error Spending Function for the Primary
Endpoint, Observed Number of All-Cause Deaths with Associated Log-Rank Statistics
Look Placebo Treatment Information Relative Observed Critical
No. Enrolled Deaths Enrolled Deaths Fraction Risk Xi ci
1 563 81 543 59 0.130 0.755 1.820 6.117
2 830 189 809 139 0.304 0.755 2.719 3.903
3 830 254 810 199 0.419 0.803 2.744 3.278
4 830 327 811 251 0.535 0.786 3.357 2.876
5 831 380 811 279 0.610 0.752 4.414 2.704
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Table 5
One-Sided 0.025-Level Lan-DeMets Boundary Using the Regular and Refined Pocock Error Spending Function for the
Secondary Endpoint, Observed Number of Sudden CV Deaths with Associated Log-Rank Statistics
Look Placebo Treatment Information∗ Relative Observed Regular Pocock Refined Pocock
No. Enrolled Deaths Enrolled Deaths Fraction Risk Yi ci ci
1 563 29 543 15 0.130 0.536 2.073 2.574 2.345
2 830 57 809 44 0.304 0.792 1.270 2.478 2.228
3 830 71 810 59 0.419 0.852 1.113 2.519 2.257
4 830 91 811 76 0.535 0.855 1.268 2.505 2.236
5 831 109 811 82 0.610 0.771 2.224 2.532 2.259
∗ These information fractions are based on all-cause mortality and are the same as in Table 4.
